United States’ First Actively Managed Psychedelics ETF Launches on NYSE Arca
PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier this year.
Author: Emily Jarvie
How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics
Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.
Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship
Podcaster and author of “The 4-Hour Work Week” will gift the university’s Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.
Detroit Voters Can Decriminalize Psychedelic Plants This November
The proposal asks voters if the city should “decriminalize to the fullest extent permitted under Michigan law the personal possession and therapeutic use of entheogenic plants by adults.”
Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve
“HPPD is a discomfort. Some people have it for 10, 15, 20 years and they regret the day they did the drug that caused it,” says the CEO of Ehave.
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials
“Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
Psychedelic Business Spotlight: September 10, 2021
This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.
University of Ottawa Offers Canada’s First Psychedelic Studies Program
And since the classes are online, students can live anywhere in the world while taking Psychedelic and Spiritual Studies courses at the university.
Michigan Senators Propose Bill Legalizing Plant-Based Psychedelics
“Decriminalization of entheogenic substances makes sense,” says Senator Jeff Irwin. “Let’s stop wasting time and money making more victims of the War on Drugs.”
Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%
The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
End of content
End of content